* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download ppt
Transposable element wikipedia , lookup
Epigenetics of depression wikipedia , lookup
United Kingdom National DNA Database wikipedia , lookup
Genealogical DNA test wikipedia , lookup
DNA damage theory of aging wikipedia , lookup
Transcription factor wikipedia , lookup
Transgenerational epigenetic inheritance wikipedia , lookup
Bisulfite sequencing wikipedia , lookup
Nucleic acid analogue wikipedia , lookup
Long non-coding RNA wikipedia , lookup
Behavioral epigenetics wikipedia , lookup
Cell-free fetal DNA wikipedia , lookup
Molecular cloning wikipedia , lookup
Human genome wikipedia , lookup
DNA vaccination wikipedia , lookup
Genomic library wikipedia , lookup
Nucleic acid double helix wikipedia , lookup
Genome evolution wikipedia , lookup
Epigenetics in stem-cell differentiation wikipedia , lookup
Designer baby wikipedia , lookup
DNA supercoil wikipedia , lookup
Epigenetics of diabetes Type 2 wikipedia , lookup
Genetic engineering wikipedia , lookup
Deoxyribozyme wikipedia , lookup
Point mutation wikipedia , lookup
Microevolution wikipedia , lookup
Extrachromosomal DNA wikipedia , lookup
Epigenetics of neurodegenerative diseases wikipedia , lookup
No-SCAR (Scarless Cas9 Assisted Recombineering) Genome Editing wikipedia , lookup
Epigenetics of human development wikipedia , lookup
Epigenetics wikipedia , lookup
Cre-Lox recombination wikipedia , lookup
Histone acetyltransferase wikipedia , lookup
Cancer epigenetics wikipedia , lookup
Primary transcript wikipedia , lookup
Vectors in gene therapy wikipedia , lookup
Epigenetics in learning and memory wikipedia , lookup
Non-coding DNA wikipedia , lookup
Site-specific recombinase technology wikipedia , lookup
Polycomb Group Proteins and Cancer wikipedia , lookup
Artificial gene synthesis wikipedia , lookup
Helitron (biology) wikipedia , lookup
Nutriepigenomics wikipedia , lookup
History of genetic engineering wikipedia , lookup
Epigenomics wikipedia , lookup
Zinc finger nuclease wikipedia , lookup
Trends in Biomedical Science 2015 Epigenetics – Editing the Epigenome 1 adapted from Opinion: Engineering the Epigenome Stephan Beck, Stefan H. Stricker and Anna Köferle | August 26, 2015 http://www.thescientist.com//?articles.view/articleNo/43837/ti tle/Opinion--Engineering-the-Epigenome/ 2 Cells can add or remove epigenetic marks. • this is called modifying the chromatin. • proteins which add or remove epigenetic marks are chromatin modifiers. • there are ways to send chromatin modifiers to particular regions of the chromosome – the modifiers are targeted to the chromosome region 3 Epigenetic processes influence how cells use genetic information. • the cell adds chemical tags onto the genome, • labels features such as genes or regulatory elements • millions of these tags—chromatin marks— have been profiled – different tissues – cell types 4 It is difficult to say how a single mark affects gene activity. If we alter chromatin marks globally through mutational approaches or pharmacological inhibition. 5 Epigenome engineering makes it possible to investigate the function of individual chromatin marks by adding them to, or removing them from single locations of interest in the genome. 6 Targeted modification • fuse –an existing chromatin modifying enzyme (or a functional part of such an enzyme) –a programmable DNA binding domain. 7 Example chromatin modifying enzymes. 8 Demethylases are enzymes that remove methyl (CH3-) groups from nucleic acids, proteins (in particular histones), and other molecules. Several families of histone demethylases act on different substrates and do different things in cellular function. 9 The DNA methyltransferase (DNA MTase) family of enzymes catalyze the transfer of a methyl group to DNA. All the known DNA methyltransferases use S-adenosyl methionine (SAM) as the methyl donor. 10 Other enzymes include those which attach or remove actyl groups, ubiquitin, phosphoryl groups, and so on. 11 Programmable DNA binding domains There are several types of DNA binding domains. 12 TALE TAL effectors (Transcription Activator-Like Effectors ) are proteins that are injected into plant cells by Xanthomonas bacterial. They enter the nucleus, bind to effectorspecific promoter sequences, and activate the expression of individual plant genes, which can either benefit the bacterium or trigger plant defenses. 13 TALE In each TAL effector, a variable number of tandem amino acid repeats (which are usually 34 residues in length), terminated by a truncated “half repeat,” recognize DNA sequences. Each of the repeats associates with one of the four nucleotides in the target site. 14 TALE The repeats are located centrally in the protein between N-terminal sequences required for bacterial type III secretion and C-terminal sequences required for nuclear localization and activation of transcription. From “The Crystal Structure of TAL Effector PthXo1 Bound to Its DNA Target.” Amanda Nga-Sze Mak et al. (2012) 10 FEBRUARY 2012 VOL 335 SCIENCE 15 16 17 Transcription Activator-Like Effectors can be used for genome editing and gene modulation 18 Transcription Activator-Like Effector Nucleases (TALENs) TALENs are engineered restriction enzymes generated by fusing the TAL effector DNA binding domain to a DNA cleavage domain (eg. FokI). 19 Transcription Activator-Like Effector Activators or Repressors Created by fusing the TAL effector DNA binding domain that targets a specific promoter region to a transcription activation or repression protein domain. 20 21 TAL effector–based sequence-specific mutagens or chromatin-modifying proteins created by fusing TAL effectors to domains such as cytidine deaminases, histone acetyltransferases or deacetylases, or DNA methyltransferases may be possible. 22 Fig. 2 Genomic control enabled by engineered TAL effector proteins. Adam J. Bogdanove, and Daniel F. Voytas Science 2011;333:1843-1846 23 Published by AAAS A Brief History of Zinc Fingers 1985 Discovery of the zinc finger protein Jonathon Miller, A. D. McLachlan, and Sir Aaron Klug first identify the repeated binding motif in Transcription Factor IIIA and are the first to use the term ‘zinc finger.' 24 1991 First crystal structure of a zinc finger Carl Pabo and Nikola Pavletich of Johns Hopkins University solve the crystal structure of zif268, now the most-commonly studied zinc finger. This paved the way for construction of binding models to describe how zinc fingers bind to DNA, setting the foundation for future custom engineering of zinc finger proteins. 25 1996 Srinivasan Chandrasegaran publishes work on fusing the Fok I nuclease to zinc fingers By attaching nuclease proteins to zinc fingers, a new genome editing tool was created. 26 2008 Rapid open source production of zinc finger nucleases becomes available Researcher Keith Joung shows how to make zinc finger nuclease proteins that bind to custom target sequences, using a bacterial two-hybrid screening system to identify specific zinc finger binders to a DNA sequence of interest. 27 28 2009 Zinc finger nuclease enters clinical trials Sangamo begins clinical trials with a zinc finger nuclease designed to target the CCR5 gene and inhibit HIV. Success of this therapeutic could prove a significant advance for gene therapy. 29 2011 Context-dependency improves open-source zinc finger engineering Keith Joung publishes tables of zinc finger binding sites that account for contextdependent effects and can be rearranged to form custom zinc finger proteins that bind to a variety of DNA sequences. This greatly increases the ease of engineering novel zinc fingers based on the structures of previously characterized zinc fingers. 30 31 32 33 Clustered, regularly interspaced, short palindromic repeat (CRISPR) technology 34 Fig. 1 Timeline of CRISPR-Cas and genome engineering research fields.Key developments in both fields are shown. Jennifer A. Doudna, and Emmanuelle Charpentier Science 2014;346:1258096 35 Published by AAAS Fig. 2 Biology of the type II-A CRISPR-Cas system.The type II-A system from S. pyogenes is shown as an example. Jennifer A. Doudna, and Emmanuelle Charpentier Science 2014;346:1258096 36 Published by AAAS Fig. 4 CRISPR-Cas9 as a genome engineering tool. Jennifer A. Doudna, and Emmanuelle Charpentier Science 2014;346:1258096 Published by AAAS Cas9 functions as an RNA-guided DNA binding protein when engineered to contain inactivating mutations in both of its active sites. Dead Cas9 (dCas9) can be fused to: •activator or repressor domains for transcriptional down-regulation or activation . •fused to fluorescent domains, (eg. GFP), for livecell imaging of chromosomal loci. •fused chromatin or DNA modification domains, to target epigenetic changes to genomic DNA. 38 Make fusion proteins which have a DNA binding domain fused to a chromatin modifying domain. 39 Zinc fingers, TALEs, and CRISPR/Cas9 proteins can be used to target changes in gene expression, "epigenome editing." Eg. fuse the gene-activating VP64 or p65 domains to an engineered DNA binding domain targeted to an endogenous gene promoter to achieve gene activation. 40 41 Zinc finger, TALE, and Cas9-gRNA platforms for editing regulatory states. Isaac B. Hilton, and Charles A. Gersbach Genome Res. 2015;25:1442-1455 42 © 2015 Hilton and Gersbach; Published by Cold Spring Harbor Laboratory Press Editing Epigenetic States. Isaac B. Hilton, and Charles A. Gersbach Genome Res. 2015;25:1442-1455 43 © 2015 Hilton and Gersbach; Published by Cold Spring Harbor Laboratory Press What do you want to change? Think of the problem then look it up in ENCODE. 44 Figure 4. ENCODE chromatin annotations in the HLA locus. The ENCODE Project Consortium (2011) A User's Guide to the Encyclopedia of DNA Elements (ENCODE). PLoS Biol 9(4): e1001046. doi:10.1371/journal.pbio.1001046 http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.1001046 45 Epigenomic enrichments of genetic variants associated with diverse traits. Roadmap Epigenomics Consortium et al. Nature 518, 317-330 (2015) doi:10.1038/nature14248 46 Epigenomic enrichments of genetic variants associated with diverse traits. Roadmap Epigenomics Consortium et al. Nature 518, 317-330 (2015) doi:10.1038/nature14248 47 Epigenomic information across tissues and marks. Roadmap Epigenomics Consortium et al. Nature 518, 317-330 (2015) doi:10.1038/nature14248 48 49 50 51 Which of the large number of catalogued chromatin marks possess real gene-regulatory capabilities? • GWAS and ENCODE involves statistical correlation of chromatin marks with expression levels of associated genes. 52 By directing chromatin modifiers to a range of sites at different genomic loci and measuring resulting changes in transcription of associated candidate genes, a number of functional chromatin marks have now been identified. • Eg. removal of methylation from lysine4 of histone H3 at enhancers and promoters with dCas9-LSD1 results in downregulation of proximal genes , while adding histone acetylation using dCas9-p300 gives upregulation. 53 Changing individual chromatin marks at relevant sites can significantly alter levels of transcription. • This effect depends both on the enzymatic activity of the chromatin modifier and its guided binding to the target site. • The biological relevance of these engineering efforts must still be established. 54 • Measuring changes in protein levels orphenotypic changes in addition to changes in mRNA levels, • or comparing engineered gene expression to physiological levels of activity • should show that changing specific chromatin marks can influence cellular behavior. 55 It will soon be possible to see the effect of altering combinations of chromatin marks by using different targeting platforms that can act independently in the same cell. 56 • The ease of targeting chromatin modifiers through an RNA-based DNA binding mechanism will help us discover functional marks using screening approaches. • Some of the findings may be translated into therapeutic use by using epigenetic engineering technologies in vivo. 57 Eg in living mice, Heller et al (2014), engineered Zinc Finger Proteins (ZFPs), which were targeted to the transcription factor, ΔFosB, which plays important roles, acting in the nucleus accumbens (Nac). The ZFPs were fused to enzymes which acetylate histones. 58 The DNA coding for the ZFPacetyltransferase was puut into a virus. The virus was injected into the nucleus accumbens. The nucleus accumbens is part of the brain which is a key brain reward region, in drug and stress action. 59 The results displayed that once ZFPs bound to the gene, histones were modified by the FosBZFPs in the area of the FosB gene, which either activated or repressed expression. Histone methylation or histone acetylation “was sufficient to control drug- and stress-evoked transcriptional and behavioral responses via interactions with the endogenous transcriptional machinery.” 60